Autonomic Materials (AMI) is launching its first product, an epoxy primer developed in partnership with a leading U.S.-based paint manufacturer that features AMI’s proprietary self-healing technology.
Ocugen, Inc., a clinical stage biopharmaceutical company developing novel treatments for sight-threatening diseases, today announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for OCU300 (brimonidine tartrate) for…
In 2016, Tianhe Stem Cell Technologies received a national grant funding ($780,000) from the National Ministry of Science and Technology in China. They received 2 national grants (total $200,000) from the National Science…
Yaso Therapeutics, Inc. announces the award of a fourth SBIR grant from the National Institutes of Health (NIH), enabling the firm to complete preclinical testing of a novel polymer, PPCM, as a contraceptive.…
Actuate Therapeutics, Inc., a Chicago-based biopharmaceutical company, today announced the appointment of Francis J. Giles, MB, MD, FRCPI, FRCPath to the newly created position of Chief Medical Officer (CMO). Dr. Giles will be…
Cancer treatment company G1 Therapeutics (Pending:GTHX) has filed proposed terms for its $100 million IPO, aiming to sell 6.25 million shares of its common stock at a midpoint price of $16.00 per share.…
Pharmaceutical giants Pfizer and Novartis were first to gain regulatory approval with drugs that block a pair of enzymes important to tumor growth in breast cancer. Clinical-stage biotech G1 Therapeutics has a different…
IllinoisVENTURES closed an investment in Cast21, a medical device company developing an alternative orthopedic cast for use in treating fractures, and EnterpriseWorks tenant. MB Venture Partners, Innova Memphis, and Bindley Capital also participated…
AddStructure, a startup star of last year’s Target + Techstars retail accelerator program, has raised $1.4 million in seed funding from Best Buy, Techstars Ventures and other parties as it continues to develop…
G1 Therapeutics, Inc., a clinical-stage oncology company, announced today the expansion of its pipeline of novel cancer therapies with the initiation of three development programs in breast cancer. G1 is enrolling a Phase…